Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.

Perosa F, Favoino E, Favia IE, Vettori S, Prete M, Corrado A, Cantatore FP, Valentini G.

Medicine (Baltimore). 2016 Jun;95(25):e3931. doi: 10.1097/MD.0000000000003931.

2.

CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.

Favoino E, Prete M, Marzullo A, Millo E, Shoenfeld Y, Perosa F.

Clin Rev Allergy Immunol. 2016 May 23. [Epub ahead of print] Review.

PMID:
27216429
3.

Antiphospholipids Syndrome Complicated by a Systemic Capillary Leak-Like Syndrome Treated With Steroids and Intravenous Immunoglobulins: A Case Report.

Prete M, Urso L, Fatone MC, Pinto V, Perosa F.

Medicine (Baltimore). 2016 Feb;95(5):e2648. doi: 10.1097/MD.0000000000002648.

4.

Vasculitides: Proposal for an integrated nomenclature.

Prete M, Indiveri F, Perosa F.

Autoimmun Rev. 2016 Feb;15(2):167-73. doi: 10.1016/j.autrev.2015.10.008. Epub 2015 Nov 6. Review.

PMID:
26546717
5.

Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin.

Perosa F, Prete M, Di Lernia G, Ostuni C, Favoino E, Valentini G.

Autoimmun Rev. 2016 Jan;15(1):102-9. doi: 10.1016/j.autrev.2015.10.001. Epub 2015 Oct 9. Review.

PMID:
26455561
6.

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis.

Favoino E, Favia IE, Vettori S, Vicenti C, Prete M, Valentini G, Perosa F.

Clin Exp Immunol. 2015 Jul;181(1):100-9. doi: 10.1111/cei.12633. Epub 2015 May 10.

7.

Raynaud's phenomenon: from molecular pathogenesis to therapy.

Prete M, Fatone MC, Favoino E, Perosa F.

Autoimmun Rev. 2014 Jun;13(6):655-67. doi: 10.1016/j.autrev.2013.12.001. Epub 2014 Jan 10. Review.

PMID:
24418302
8.

Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature.

Prete M, Fatone MC, Vacca A, Racanelli V, Perosa F.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):267-74. Epub 2013 Dec 16. Review.

PMID:
24351505
9.

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice.

Favoino E, Favia EI, Digiglio L, Racanelli V, Shoenfeld Y, Perosa F.

Clin Exp Immunol. 2014 Jan;175(1):32-40. doi: 10.1111/cei.12208.

10.

MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.

Leone P, Shin EC, Perosa F, Vacca A, Dammacco F, Racanelli V.

J Natl Cancer Inst. 2013 Aug 21;105(16):1172-87. doi: 10.1093/jnci/djt184. Epub 2013 Jul 12. Review.

11.

Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis.

Perosa F, Favoino E, Cuomo G, Digiglio L, Dammacco F, Prete M, Valentini G, Racanelli V.

Arthritis Res Ther. 2013 Jul 9;15(4):R72. doi: 10.1186/ar4249.

12.

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis.

Favoino E, Digiglio L, Cuomo G, Favia IE, Racanelli V, Valentini G, Perosa F.

PLoS One. 2013 Apr 22;8(4):e61453. doi: 10.1371/journal.pone.0061453. Print 2013.

13.

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Cavo M, Pantani L, Petrucci MT, Patriarca F, Zamagni E, Donnarumma D, Crippa C, Boccadoro M, Perrone G, Falcone A, Nozzoli C, Zambello R, Masini L, Furlan A, Brioli A, Derudas D, Ballanti S, Dessanti ML, De Stefano V, Carella AM, Marcatti M, Nozza A, Ferrara F, Callea V, Califano C, Pezzi A, Baraldi A, Grasso M, Musto P, Palumbo A; GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network.

Blood. 2012 Jul 5;120(1):9-19. doi: 10.1182/blood-2012-02-408898. Epub 2012 Apr 12.

14.

Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections.

Racanelli V, Brunetti C, De Re V, Caggiari L, De Zorzi M, Leone P, Perosa F, Vacca A, Dammacco F.

PLoS One. 2011;6(9):e25606. doi: 10.1371/journal.pone.0025606. Epub 2011 Sep 28.

15.

Extra-articular manifestations of rheumatoid arthritis: An update.

Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F.

Autoimmun Rev. 2011 Dec;11(2):123-31. doi: 10.1016/j.autrev.2011.09.001. Epub 2011 Sep 10. Review.

PMID:
21939785
16.

Autoantibodies to intracellular antigens: generation and pathogenetic role.

Racanelli V, Prete M, Musaraj G, Dammacco F, Perosa F.

Autoimmun Rev. 2011 Jun;10(8):503-8. doi: 10.1016/j.autrev.2011.03.001. Epub 2011 Mar 22. Review.

PMID:
21397735
17.

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C, Caravita T, Tosi P, Baccarani M; GIMEMA Italian Myeloma Network.

Lancet. 2010 Dec 18;376(9758):2075-85. doi: 10.1016/S0140-6736(10)61424-9. Epub 2010 Dec 9. Erratum in: Lancet. 2011 Nov 26;378(9806):1846.

PMID:
21146205
18.

The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3).

Perosa F, Vicenti C, Racanelli V, Leone P, Valentini G, Dammacco F.

Clin Immunol. 2010 Oct;137(1):60-73. doi: 10.1016/j.clim.2010.06.008. Epub 2010 Jul 13.

PMID:
20630806
19.

CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.

Perosa F, Prete M, Racanelli V, Dammacco F.

J Intern Med. 2010 Mar;267(3):260-77. doi: 10.1111/j.1365-2796.2009.02207.x. Review.

20.

Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma.

Racanelli V, Leone P, Frassanito MA, Brunetti C, Perosa F, Ferrone S, Dammacco F.

Blood. 2010 Feb 11;115(6):1185-93. doi: 10.1182/blood-2009-06-228676. Epub 2009 Dec 11.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk